MedTrace Logo

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

NCT06090630 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2024-04-17

No results posted yet for this study

Summary

This trial studies how well an imaging technique called magnetic resonance (MR) spectroscopic imaging works in identifying breast cancer in women with benign or suspicious areas in the breast. Magnetic resonance imaging (MRI) is a diagnostic tool used to investigate the location of tumors in different organs. Since radiological pictures do not have sufficient information for tumor grades, invasive procedure such as biopsy is performed on patients with breast cancers for diagnosis. Breast tissue contains water, fat, and chemicals known as metabolites. MR spectroscopic imaging may help to characterize the various breast metabolite steady state levels and identify the differences between necrosis and tumor recurrence, which is difficult using radiological procedures such as MRI.

Conditions

  • Benign Breast Neoplasm
  • Breast Carcinoma
  • Malignant Breast Neoplasm

Interventions

PROCEDURE

Diffusion Weighted Imaging

Undergo DWI-MRI

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MR spectroscopic imaging

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED

  • U.S. Army Medical Research Acquisition Activity

    collaborator FED

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Michael A Thomas · UCLA / Jonsson Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2023-02-03
Completion
2023-02-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06090630 on ClinicalTrials.gov